2 Stocks Down 17% and 21% to Buy Right Now

Key Points DexCom's innovative devices, network effect, and large growth opportunities could help it turn things around. Regeneron Pharmaceuticals is making strides toward putting a recent patent cliff in the rearview mirror. 10 stocks we like better than DexCom › One way to earn above-average market returns -- which isn't always easy -- is to invest in companies that have lagged the market but are likely to recover over the long run. As the basic investing maxim goes, "Buy low, sell high." That b ...